PQ 379
379. Deputy John Brassil asked the Minister for Health the number of health technology assessments carried out by the National Centre for Pharmacoeconomics since 2016 in view of the fact that page 6 of the NCPE’s health technology assessment submission applicant template indicated that the medicine has an orphan designation from the European Medicines Agency; the number of these medicines that have since been added to the reimbursement list; the combined cost of these reimbursed medicines per annum; and if he will make a statement on the matter. [38835/18]
Introduced
25 September 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
25 September 2018
Summary
379. Deputy John Brassil asked the Minister for Health the number of health technology assessments carried out by the National Centre for Pharmacoeconomics since 2016 in view of the fact that page 6 of the NCPE’s health technology assessment submission applicant template indicated that the medicine has an orphan designation from the European Medicines Agency; the number of these medicines that have since been added to the reimbursement list; the combined cost of these reimbursed medicines per annum; and if he will make a statement on the matter. [38835/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
National Centre for Pharmacoeconomics
National Centre for Pharmacoeconomics
xml · EN · 25 September 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-09-25/379/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-09-25/pq_379